We have written on a lot of different topics on the Healthworks Collective blog over the years. Something that stands out in discussions about pharma practitioners is how they approach chronic illness with a long-term view that balances treatment, monitoring, and patient education.
A report from the CDC states that an estimated 129 million people in the U.S. have at least one major chronic disease, which drives much of the strategy behind pharmaceutical care. There are growing expectations for practitioners to coordinate medications, track outcomes, and support patients managing multiple conditions at once. Another thing to consider is how this scale of chronic illness forces a shift toward prevention and adherence, rather than short-term symptom relief. Keep reading to learn more.
How Pharma Practitioners Navigate Complex Chronic Conditions
Imani Telesford, Matthew McGough, Delaney Tevis, and Lynne Cotter wrote in the Kaiser Family Foundation Health System Tracker that obesity is the most prevalent chronic illness in the U.S., affecting 42% of the population in 2022.
“Many chronic conditions or risk factors can interact or contribute to one another, resulting in multiple morbidities. Conditions are not mutually exclusive, someone can have multiple conditions at once, each potentially exacerbating the others. For example, among people with diabetes, 11% also have major depressive disorder, and among adults (40-64 years) with obesity, over 60% have hypertension and 30% have type 2 diabetes; comorbidities also increase with age,” the authors write.
It is common for pharma practitioners to design treatment plans that account for overlapping conditions and drug interactions across these patient groups. You often see a focus on medication synchronization, lifestyle counseling, and regular follow-ups to prevent complications. Something that defines this approach is the need to personalize care while still managing large patient populations with shared risk factors.
You come in with fatigue, joint pain, or persistent brain fog. A diagnosis is made, a prescription is written, and you leave feeling like something has been addressed.
But practitioners of biological medicine would argue that something important was skipped over entirely, namely, why those symptoms appeared in the first place.
The answer Dr. Roger S. Jaynes has arrived at, after more than three decades in practice, is deceptively simple: the body already knows how to heal. Clear the path, and it will.
Taking Out the Trash
The framing Dr. Jaynes uses with patients is deliberately unglamorous.
“Changing the body’s terrain by eliminating toxins rather than driving toxins deeper into the body,” he explains. “Basically taking out the trash.”
Biological medicine starts from the premise that many chronic symptoms, the fatigue, the aches, the sluggish cognition, are not the problem itself. They are the body’s attempt to flag a problem. A growing toxic burden, accumulated from environmental exposure, poor elimination, and the general demands of modern life, can overwhelm the body’s regulatory systems and produce a cascade of seemingly unrelated complaints.
Treating those complaints in isolation, with pharmaceuticals designed to suppress the signal, leaves the underlying load untouched. The symptoms may quieten for a while. The terrain, as Dr. Jaynes would put it, remains unchanged.
A German Instrument That Starts With Why
One of the most telling differences in Dr. Jaynes’s clinical method is how a patient encounter begins.
Rather than cataloging symptoms and cross-referencing a diagnostic manual, he starts with electrodermal screening, a German instrument designed to find “the root cause of the complaint or symptom.” Conventional intake processes are typically organized around what a patient feels. This process is organized around what the body is actually doing.
The instrument identifies which systems are under stress and, critically, what is driving that stress. From there, it informs which remedies, drawn from a portfolio that includes Marco Pharma products such as Lymphonest, Allernest, and Marcozyme, are likely to create meaningful change. The aim is resolution, not management.
Aluminum, Gut pH, and What Accumulates
The conversation about toxins can quickly become abstract, so it’s worth getting specific about what biological medicine practitioners mean.
Environmental exposures accumulate. Aluminum, for instance, builds up in tissues over time and can become a significant contributor to systemic dysfunction. Dr. Jaynes uses cilantro and chlorella specifically to help eliminate the buildup of aluminum and other toxins, a targeted approach to clearing what the body has stored, rather than waiting passively for symptoms to worsen.
The gut plays a central role in this picture. When gut pH falls out of its optimal range, the environment becomes less effective at managing waste and regulating immune response. Ba-Co-Flor, one of the Marco Pharma formulations Dr. Jaynes regularly incorporates, works specifically to alkalise the gut, a foundational adjustment that supports broader detoxification rather than targeting a single condition. The logic is systemic, not symptomatic.
What makes these formulations different from what you might pick up elsewhere, in Dr. Jaynes’s view, is purity and reliability. “These are a pure way of producing products that are effective,” he says, and having used them consistently for 34 years, that reliability has been tested across tens of thousands of patient encounters.
90 Days, Not a Fortnight
One of the more uncomfortable truths about genuine detoxification is that it takes time.
Real structural change, the kind that reduces toxic load and restores regulatory function, doesn’t happen in a fortnight. In Dr. Jaynes’s clinical experience, most patients move through a 90-day healing cycle. That said, he notes they “tend to feel better in a week or so,” which is an important distinction. Symptomatic improvement and full restoration are two different milestones on the same journey.
Monthly re-testing lets him measure the level of toxic activity directly and adjust protocols accordingly. Healing is treated as a process that can be tracked, not just reported, a meaningfully different relationship with patient progress than the before-and-after model that most clinical frameworks operate on.
The results, across more than three decades of practice, have occasionally surprised even Dr. Jaynes. In some patients, targeted biological remedies have contributed to outcomes that conventional medicine tends to manage indefinitely rather than resolve, including the reduction of cystic fibroids in the ovaries and breasts, and the easing of hot flashes. These are not marginal edge cases in his experience. They reflect what can happen when the body’s own regulatory capacity is properly supported, rather than overridden.
A Different Starting Point
The philosophy of biological medicine doesn’t require a wholesale rejection of conventional care to make sense.
What it does require is a willingness to ask whether a treatment is addressing the condition itself or the signals the body sends when that condition persists. Marco Pharma’s product line, the formulations Dr. Jaynes has worked with since 1987, is built around the principle that quality, purity, and biological specificity are what allow remedies to do meaningful work at the level of root cause. Not more of the same noise, more loudly.
“Basically taking out the trash,” as Dr. Jaynes puts it, sounds simple.
The underlying shift in clinical thinking it represents is anything but. Symptoms are not the enemy. They are information. And the most useful thing a practitioner can do with that information is follow it back to the source.
About Dr. Jaynes
Dr. Roger S. Jaynes is a chiropractor and certified classical homeopathic practitioner based in Greenville, South Carolina, where he has been in practice since 1987. Trained at Sherman College, Texas Chiropractic College, and Medicine Week in Baden Baden, Germany, he combines chiropractic care with classical homeopathy, electrodermal screening, and biological medicine. For over 34 years, he has incorporated Marco Pharma International products into his patient protocols, focusing on lymphatic drainage, respiratory support, and gut health.
Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Statements regarding Marco Pharma International’s products have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
